Literature DB >> 22158475

Glomerular disease in 2011: New clues to environmental influences in glomerular disease.

Peter J Nelson1, Charles E Alpers.   

Abstract

Research into genetic susceptibilities for proteinuric glomerular diseases has uncovered key pathogenic contributions from inheritable defects in podocytes. However, much less is known about environmental factors that may initiate or propagate podocyte injury. Seminal reports in 2011 provided new mechanistic insights into how this may occur.

Entities:  

Mesh：

Year:  2011        PMID： 22158475     DOI： 10.1038/nrneph.2011.214

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


  9 in total

1.  Early-childhood membranous nephropathy due to cationic bovine serum albumin.

Authors:  Hanna Debiec; Florence Lefeu; Markus J Kemper; Patrick Niaudet; Georges Deschênes; Giuseppe Remuzzi; Tim Ulinski; Pierre Ronco
Journal:  N Engl J Med       Date:  2011-06-02       Impact factor: 91.245

Review 2.  The renal mononuclear phagocytic system.

Authors:  Peter J Nelson; Andrew J Rees; Matthew D Griffin; Jeremy Hughes; Christian Kurts; Jeremy Duffield
Journal:  J Am Soc Nephrol       Date:  2011-12-01       Impact factor: 10.121

Review 3.  Genetics of nephrotic syndrome: connecting molecular genetics to podocyte physiology.

Authors:  Eduardo Machuca; Geneviève Benoit; Corinne Antignac
Journal:  Hum Mol Genet       Date:  2009-10-15       Impact factor: 6.150

Review 4.  Human nutrition, the gut microbiome and the immune system.

Authors:  Andrew L Kau; Philip P Ahern; Nicholas W Griffin; Andrew L Goodman; Jeffrey I Gordon
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

Review 5.  Gene-environment interactions in chronic inflammatory disease.

Authors:  Harald Renz; Erika von Mutius; Per Brandtzaeg; William O Cookson; Ingo B Autenrieth; Dirk Haller
Journal:  Nat Immunol       Date:  2011-04       Impact factor: 25.606

6.  Severity of asthma is related to endotoxin in house dust.

Authors:  O Michel; J Kips; J Duchateau; F Vertongen; L Robert; H Collet; R Pauwels; R Sergysels
Journal:  Am J Respir Crit Care Med       Date:  1996-12       Impact factor: 21.405

7.  Role of mTOR in podocyte function and diabetic nephropathy in humans and mice.

Authors:  Markus Gödel; Björn Hartleben; Nadja Herbach; Shuya Liu; Stefan Zschiedrich; Shun Lu; Andrea Debreczeni-Mór; Maja T Lindenmeyer; Maria-Pia Rastaldi; Götz Hartleben; Thorsten Wiech; Alessia Fornoni; Robert G Nelson; Matthias Kretzler; Rüdiger Wanke; Hermann Pavenstädt; Dontscho Kerjaschki; Clemens D Cohen; Michael N Hall; Markus A Rüegg; Ken Inoki; Gerd Walz; Tobias B Huber
Journal:  J Clin Invest       Date:  2011-05-23       Impact factor: 14.808

Review 8.  Regulation of cell signalling by uPAR.

Authors:  Harvey W Smith; Chris J Marshall
Journal:  Nat Rev Mol Cell Biol       Date:  2010-01       Impact factor: 94.444

9.  Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis.

Authors:  Changli Wei; Shafic El Hindi; Jing Li; Alessia Fornoni; Nelson Goes; Junichiro Sageshima; Dony Maiguel; S Ananth Karumanchi; Hui-Kim Yap; Moin Saleem; Qingyin Zhang; Boris Nikolic; Abanti Chaudhuri; Pirouz Daftarian; Eduardo Salido; Armando Torres; Moro Salifu; Minnie M Sarwal; Franz Schaefer; Christian Morath; Vedat Schwenger; Martin Zeier; Vineet Gupta; David Roth; Maria Pia Rastaldi; George Burke; Phillip Ruiz; Jochen Reiser
Journal:  Nat Med       Date:  2011-07-31       Impact factor: 53.440
  9 in total
  2 in total

1.  VEGF genetic polymorphisms may contribute to the risk of diabetic nephropathy in patients with diabetes mellitus: a meta-analysis.

Authors:  Li Sun; Quan Yuan; Ning Cao; Wei Guo; Li Yao; Jiang-Min Feng; Jian-Fei Ma; Li-Ning Wang
Journal:  ScientificWorldJournal       Date:  2014-08-11

Review 2.  Vitamin D receptor gene polymorphisms in association with diabetic nephropathy: a systematic review and meta-analysis.

Authors:  Lina Yang; Lan Wu; Yi Fan; Jianfei Ma
Journal:  BMC Med Genet       Date:  2017-08-29       Impact factor: 2.103
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.